Skip to main content
Accessibility|Contact|Privacy|Terms of Service

Diabetes Drugs for Diabetics with Kidney Disease

  • Published: 2011-11-12 (Revised/Updated 2014-03-14) : Author: American Society of Nephrology
  • Synopsis: Some blood sugar lowering drugs have caused kidney problems in patients Sitagliptin is safer and as effective as glipizide in patients with Type 2 diabetes and chronic kidney disease.

Main Document

"Previous research indicates that the diabetes drugs sitagliptin and glipizide may not cause considerable kidney damage."

Which diabetes drug is best for diabetics with kidney disease- Sitagliptin is safer and as effective as glipizide in patients with Type 2 diabetes and chronic kidney disease.

Sitagliptin is as effective as glipizide at lowering blood sugar levels in patients with type 2 diabetes and chronic kidney disease.

Some blood-sugar-lowering drugs have caused kidney problems in patients with type 2 diabetes, so physicians are especially cautious when prescribing these agents to diabetics who also have chronic kidney disease (CKD).

Previous research indicates that the diabetes drugs sitagliptin and glipizide may not cause considerable kidney damage. New clinical trial results presented during the American Society of Nephrology's Annual Kidney Week compared the two drugs.

Sitagliptin and glipizide act on different targets but generate the same result - they boost the effects of insulin, which lowers blood sugar levels.

Juan Arjona Ferreira, MD, (MSD Corp.) and his colleagues conducted a 54-week study to compare the efficacy and safety of sitagliptin and glipizide in patients with type 2 diabetes and moderate or severe CKD who were not on dialysis. The researchers randomized 426 patients to receive sitagliptin or glipizide.

Among the major findings at the end of the study:

Blood glucose levels dropped to a similar extent in patients in both groups.

Patients receiving sitagliptin were less likely to experience hypoglycemia - or dangerously low blood sugar levels - than patients receiving glipizide (6.2% vs 17.0%).

Patients who took sitagliptin tended to lose a small amount of weight, while most patients who took glipizide experienced a slight weight gain.

Study authors for "Efficacy and Safety of Sitagliptin vs. Glipizide in Patients with Type 2 Diabetes and Moderate to Severe Chronic Renal Insufficiency" (abstract LB-PO3166) include Juan Arjona Ferreira, MD, Michel Marre, MD, PhD, George Bakris, MD, and Ton Rabelink, MD, PhD.

Disclosures: Juan Arjona Ferreira is employed by and has ownership interest in Merck Sharp & Dohme, Corp. Michel Marre receives honoraria from is a scientific adviser for or has other relationships with Abbott, Eli Lilly, MSD, Novo Nordisk, Sanofi Aventis, and Servier. George Bakris has consultancy agreements with CVRx, Relapsya, Johnson & Johnson, Medtronic, Merck, Abbott, Takeda, and Reata; and receives research funding from Novartis, Forest, and Takeda. Ton Rabelink receives speaker fees from Daiichi Sankyo.

ASN Kidney Week 2011, the largest nephrology meeting of its kind, will provide a forum for 13,000 professionals to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. Kidney Week 2011 will take place November 8 - November 13 at the Pennsylvania Convention Center in Philadelphia, PA.

Founded in 1966, and with more than 12,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

Similar Topics

1 : Prediabetes: The Best Bad News You Can Get : Blue Cross and Blue Shield of Minnesota.
2 : Diabetes Type 1 and 2 On The Rise Among Children and Teens : Centers for Disease Control and Prevention.
3 : Dairy Proteins May Help Control Insulin and Blood Glucose Levels : California Dairy Research Foundation.
4 : Diabetic Foot Care During Winter Months : American College of Foot and Ankle Surgeons.
5 : Diabetes: Dementia & Aging : Thomas C. Weiss.
From our Diabetes section - Full List (65 Items)


Submit disability news, coming events, as well as assistive technology product news and reviews.


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.





1 : Telemedicine Helps Overcome Healthcare Gender Based Barriers
2 : Screen Reader Plus Keyboard Helps Blind, Low-Vision Users Browse Modern Webpages
3 : Our Digital Remains Should be Treated with Same Care and Respect as Physical Remains
4 : Tungsten: Concern Over Possible Health Risk by Human Exposure to Tungsten
5 : Student Loan Discharge Process for Disabled Veterans Made Easier
6 : Growing Bone and Cartilage Tissues for Humans from Flaxseed Like Particles
7 : Throat Reflexes Differ in People with Tetraplegia and Sleep Apnea
8 : UTA Grant to Help Minority Students Link Assistive Technology with Disability Studies
9 : Body Probe as Thin as a Hair Has Imaging Function and Temperature Sensor
10 : Dripping Candle Wax Bone Disease (Melorheostosis) Cause Solved


Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.

© 2004 - 2018 Disabled World™